| CG22 |
Anxiety (CG22) (replaced by CG113) |
|
-
-
Anxiety: management of anxiety (panic disorder, with or without agoraphobia, and generalised anxiety disorder) in adults in primary, secondary and community care.
This guidance has been replaced by CG113 Anxiety
Amendment of recommendations concerning venlafaxine: April 2007
On 31 May 2006 the MHRA issued revised prescribing advice for venlafaxine. This amendment brings the guideline into line with the new advice but does not cover other areas where new evidence may be available. NICE expects to make a decision on a full update later in 2007.The amendments to the recommendations to take account of the revised prescribing advice for venlafaxine were developed by the National Collaborating Centre for Mental Health.
-
Other information
How this guidance was produced
Background information
- None found
This page was last updated: 20 December 2011
-
Guideline formats
-
Implementation tools and resources
- None available
See this guidance in practice
Patient
The summary of the key recommendations in the guidance written for patients, carers and those with little medical knowledge and may be used in local patient information leaflets.
Quick Reference Guide
The quick reference guide presents recommendations for health professionals
NICE Guideline
The published NICE clinical guideline, contains the recommendations for health professionals and NHS bodies.
Full Guideline
The published full clinical guideline for specialists with background, evidence, recommendations and methods used.
